According to a recent *report, the global surface disinfectant market is expected to reach USD 1,251.6 Million by 2024 from USD 836.7 Million in 2019, at a CAGR of 8.4% during the forecast period. The growth of this market is majorly driven by the increasing prevalence of hospital-acquired infections (HAIs) globally, the presence of stringent regulations for the use of surface disinfectants (in hospitals, diagnostic laboratories, pharmaceutical, biotechnology companies, and research laboratories), and advancements in surface disinfectants.
The surface disinfectants market, based on composition, is segmented into alcohols, chlorine compounds, quaternary ammonium compounds, hydrogen peroxide, peracetic acid, and other compositions. The alcohols segment dominated the market in 2019. The peracetic acid segment is expected to grow at a higher growth rate. The large of the alcohols segment is attributed to high use of alcohols on hard surfaces in hospitals and laboratories. Based on application, the surface disinfectants market is segmented into surface disinfection, instrument disinfection, and other applications. In 2019, the surface disinfection segment was projected to account for the largest share of the market. The large share of this segment is attributed to the high prevalence of hospital-acquired infections across the globe and the higher volume of disinfectants required to clean these surfaces.
The global surface disinfectants market is segmented into five major regions, namely, North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East and Africa. The North American market is expected to account for the highest market share in 2020. The large share of this market segment can be attributed to a rising incidence of nosocomial infections, rising geriatric population, and improvements in healthcare infrastructure.
BIOSAFE Defenses is developing,** and in the process of submitting applications for EPA approval, a disposable, antimicrobial wipe treated with our patented light-activated antimicrobial. Created specifically for healthcare environments and shown in university testing to inhibit bacterial growth for up to four hours, these wipes are strongly attracted to microbial adhesion and are highly effective in eradicating elusive bacteria, fungi, and viruses and preventing the regrowth of deadly biofilms. The best part? Our antimicrobial compounds are fluorescent. A bright glow that’s emitted we believe will play an important role in signaling efficacy. Conversely, a dull glow signals it’s time for application or re-application. No other disinfecting product on the market today that we know of does this.
Our initial antimicrobial wipes for health care will be for noncritical surfaces and soon after we will be expanding the product line into antimicrobial products for semi-critical and critical surfaces.
**Pending EPA approval
Strategic Anticipated Outcomes
BROAD SPECTRUM ACTIVITY
Effective against a wide range of disease-causing pathogens.
PREDICTIVE KILL WINDOW
The only antimicrobial that signals the need for re-application.
COMBAT DRUG RESISTANCE
Light-induced cell-damaging ROS kills antibiotic-resistant strains of bacteria with ease.
Control biofilm growth with our self-cleaning surfaces.
Easier and more effective than NanoSilver.
Retain killing power in the presence of commonly used detergents.
SAFE TO USE
Our antimicrobials are tough on microbes, but tested and proven not to irritate skin.
LEVERAGE TECH PLATFORM
Today health care and biodefense, tomorrow food service. Killing microbes is our strength.
Learn more. Contact us now.
* Pending EPA approval.